DaVita HealthCare (DVA) ended the recent trading session at $193.86, demonstrating a +1.55% change from the preceding day's closing price. The stock's performance was ahead of the S&P 500's daily loss ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Paving Career Paths to Economic Mobility NORTHAMPTON, MA / ACCESS Newswire / / Sustainable career growth is about unlocking ...

Shares of DaVita Inc. slid 5.56% to $183.09 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 1.14% to 7,637.76 and the Dow ...

DaVita Inc. stock traded around USD 183 on September 17, 2026 after a 5.6 percent drop put it among the S&P 500’s top losers. Institutional demand stayed strong as Bank of America Corp DE disclosed a ...

DaVita is one of the largest kidney care providers in the world, with both in-center and home dialysis options. While DaVita isn't a traditional health system, the organization does operate inpatient ...

Add Yahoo as a preferred source to see more of our stories on Google. Roughly two months after dialysis giant DaVita lost a Supreme Court case involving insurance coverage for its services, Congress ...

UnitedHealth strikes a $4.9 billion deal to acquire the DaVita Medical Group unit from kidney dialysis firm DaVita in an all-cash transaction. Last month, DMG posted a $5 million operating loss in the ...

International expansion continues with new clinics in Brazil, Ecuador, Chile, and Colombia, supporting long-term growth beyond the US market. DaVita's stock offers a 10% FCF yield, and the share count ...

DaVita Inc. stock closed at USD 181.55 on the NYSE on September 11, 2026, nearly flat for the day. Bank of America has raised ...

Healthcare sector beat the S&P 500 in August, led by Moderna’s surge. See top gainers/detractors and what to watch ...

Investing.com - Health-care stocks have mostly lagged the broader market this September, but one name in the sector just handed our Strategies models a standout win. DaVita’s better-than-expected 2026 ...